中文名稱：兔抗ERBB2 (Phospho-Tyr877)多克隆抗體

英文名稱： Anti-ERBB2 (Phospho-Tyr877) rabbit polyclonal antibody

別名： NEU; NGL; HER2; TKR1; CD340; HER-2; MLN 19; HER-2/neu

相關(guān)類別： 一抗

儲存： 冷凍（-20℃）避光

宿主： Rabbit

抗原： ERBB2 (Phospho-Tyr877)

反應(yīng)種屬： Human, Mouse, Rat

標記物： Unconjugate

克隆類型： rabbit polyclonal

技術(shù)規(guī)格

Background:

This gene encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Allelic variations at amino acid positions 654 and 655 of isoform a (positions 624 and 625 of isoform b) have been reported, with the most common allele, Ile654/Ile655, shown here. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. Alternative splicing results in several additional transcript variants, some encoding different isoforms and others that have not been fully characterized.

Applications:

WB, IHC, IF

Name of antibody:

ERBB2 (Phospho-Tyr877)

Immunogen:

Synthetic peptide of human ERBB2 (Phospho-Tyr877)

Full name:

v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) (Phospho-Tyr877)

Synonyms：

NEU; NGL; HER2; TKR1; CD340; HER-2; MLN 19; HER-2/neu

SwissProt:

P04626

IHC positive control:

Human breast carcinoma

IHC Recommend dilution:

50-100

WB Predicted band size:

138 kDa

WB Positive control:

A431 cells untreated or treated with EGF

WB Recommended dilution:

500-1000

IF Positive control:

MCF7 cells

IF Recommended dilution

100-200

展開全部

兔抗ERBB2 (Phospho-Tyr877)多克隆抗體說明書
下載

欧美一级免费-欧美一级免费观看-欧美一级免费看-欧美一级免费片-jizzjizz大全-jizzjizz国产精品

021-54845833/15800441009

ELISA試劑盒

PCR試劑盒

生化試劑盒

細胞系

細胞庫

基礎(chǔ)培養(yǎng)基

完全培養(yǎng)基

原代細胞

細胞專用培養(yǎng)基

菌株

生化試劑

病理染色液

科研抗體

標準品

血清

產(chǎn)品中心

最新產(chǎn)品

相關(guān)文章

兔抗ERBB2 (Phospho-Tyr877)多克隆抗體

Background:	This gene encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Allelic variations at amino acid positions 654 and 655 of isoform a (positions 624 and 625 of isoform b) have been reported, with the most common allele, Ile654/Ile655, shown here. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. Alternative splicing results in several additional transcript variants, some encoding different isoforms and others that have not been fully characterized.
Applications:	WB, IHC, IF
Name of antibody:	ERBB2 (Phospho-Tyr877)
Immunogen:	Synthetic peptide of human ERBB2 (Phospho-Tyr877)
Full name:	v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) (Phospho-Tyr877)
Synonyms：	NEU; NGL; HER2; TKR1; CD340; HER-2; MLN 19; HER-2/neu
SwissProt:	P04626
IHC positive control:	Human breast carcinoma
IHC Recommend dilution:	50-100
WB Predicted band size:	138 kDa
WB Positive control:	A431 cells untreated or treated with EGF
WB Recommended dilution:	500-1000
IF Positive control:	MCF7 cells
IF Recommended dilution	100-200